» Articles » PMID: 8772871

Myelofibrosis Secondary to SLE and Its Reversal on Steroid Therapy

Overview
Journal Indian Pediatr
Specialty Pediatrics
Date 1995 Nov 1
PMID 8772871
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Reversible myelofibrosis secondary to systemic lupus erythematosus.

Reddy M, Boloor A, Thomas N BMJ Case Rep. 2023; 16(8).

PMID: 37591626 PMC: 10441047. DOI: 10.1136/bcr-2023-255229.


Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Anderson E, Shah B, Davidson A, Furie R Semin Arthritis Rheum. 2018; 48(1):90-104.

PMID: 29395255 PMC: 5993585. DOI: 10.1016/j.semarthrit.2017.12.004.


Haematological manifestations of lupus.

Fayyaz A, Igoe A, Kurien B, Danda D, James J, Stafford H Lupus Sci Med. 2015; 2(1):e000078.

PMID: 25861458 PMC: 4378375. DOI: 10.1136/lupus-2014-000078.


Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review.

Chalayer E, Ffrench M, Cathebras P Springerplus. 2014; 3:349.

PMID: 25045617 PMC: 4101126. DOI: 10.1186/2193-1801-3-349.


Idiopathic myelofibrosis in an infant.

Bavikar R, Kulkarni R, Rathod A, Hastak M Indian J Pediatr. 2010; 78(6):734-6.

PMID: 21188553 DOI: 10.1007/s12098-010-0340-6.